Liangfeng Tang

Liangfeng Tang

Auto-generated profile, based on publicly available information

Liangfeng Tang

Children's Hospital of Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2023 in JMIR Formative Research
Verified
Journal Article
Open access
XZXiaobo Zhang
Xiaobo Zhang
YGYing Gu
Ying Gu
JYJie Yin
Jie Yin
YZYuejie Zhang
Yuejie Zhang
Cheng JinCheng Jin
Cheng Jin
RFRui Feng
Rui Feng
Background: Medical artificial intelligence (AI) has significantly contributed to decision support for disease screening, diagnosis, and management. With the growing number of medical AI developments and applications, incorporating ethics is considered essential to avoiding harm and ensuring broad benefits in the lifecycle of medical AI. One of the premises for effectively implementing ethics in Medical AI research necessitates researchers' comprehensive knowledge, enthusiastic attitude, and practical experience. However, there is currently a lack of an available instrument to measure these aspects. Objective: The aim of this study was to develop a comprehensive scale for measuring the knowledge, attitude, and practice of ethics implementation among medical AI researchers, and to evaluate its measurement properties. Methods: The construct of the Knowledge-Attitude-Practice in Ethics Implementation (KAP-EI) scale was based on the Knowledge-Attitude-Practice (KAP) model, and the evaluation of its measurement properties was in compliance with the COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) reporting guidelines for studies on measurement instruments. The study was conducted in 2 phases. The first phase involved scale development through a systematic literature review, qualitative interviews, and item analysis based on a cross-sectional survey. The second phase involved evaluation of structural validity and reliability through another cross-sectional study. Results: The KAP-EI scale had 3 dimensions including knowledge (10 items), attitude (6 items), and practice (7 items). The Cronbach α for the whole scale reached .934. Confirmatory factor analysis showed that the goodness-of-fit indices of the scale were satisfactory (χ2/df ratio:=2.338, comparative fit index=0.949, Tucker Lewis index=0.941, root-mean-square error of approximation=0.064, and standardized root-mean-square residual=0.052). Conclusions: The results show that the scale has good reliability and structural validity; hence, it could be considered an effective instrument. This is the first instrument developed for this purpose.

1 February 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
ZGZicong Ge
Zicong Ge
LTLiangfeng Tang
Liangfeng Tang
YPYunsong Peng
Yunsong Peng
MZMingming Zhang
Mingming Zhang
JTJialong Tang
Jialong Tang
GYGang Yuan
Gang Yuan

25 April 2022 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
JLJialin Liu
Jialin Liu
YBYunli Bi
Yunli Bi
YLYing Liu
Ying Liu
LTLiangfeng Tang
Liangfeng Tang
AWAnle Wang
Anle Wang

17 September 2021 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
LTLiang-Feng Tang
Liang-Feng Tang
YBYunli Bi
Yunli Bi
YFYong Fan
Yong Fan
YLYing Liu
Ying Liu
YSYu-Bo Sun
Yu-Bo Sun
AWAn-Le Wang
An-Le Wang
Background: Lower urinary tract symptoms (LUTs) are common in young boys with posterior urethral valves (PUVs). It is crucial to investigate the characteristics of PUV patients with and without LUTs after valve ablation. Methods: Between January 2017 and December 2019, PUV patients visited Children's Hospital, Fudan University for following up were enrolled. Medical records and information from the patients' urodynamic studies (UDS) were reviewed. Results: A total of 54 enrolled PUV patients were divided into symptomatic PUV group (28 cases) and non-symptomatic PUV group (26 cases) according to daytime incontinence or not, and 21 OAB cases without structural abnormalities were set as UDS control group. The non-symptomatic PUV patients had lager filling volume (135 +/- 46% of EBC) than the symptomatic PUV patients and OAB patients (106.1 +/- 44.4% of EBC, p = 0.0255 and 88.1 +/- 39.6% of EBC, p = 0.0007, respectively). The detrusor pressure at 1/4 and 3/4 of full filling was higher in PUV groups than the control group, but no significant difference was found between the PUV groups. PUV patients with LUTs had a higher rate (19/28, 67.9%) of impaired bladder compliance than non-symptomatic PUV patients (11/26, 42.3%, p = 0.0489). The PUV patients with LUTs had a trend of worse kidney functions in lower GFR, higher serum creatinine and lower estimated GFR. Conclusion: PUV patients have higher detrusor pressure regardless of the presence or absence of LUT symptoms. Bladder function assessments are needed in boys with PUV, even without incontinence symptoms after valve ablation.

21 August 2017 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
LTLiangfeng Tang
Liangfeng Tang
HZHaijun Zhong
Haijun Zhong
Hong ChenHong Chen
Hong Chen
JSJian Shen
Jian Shen
YBYunli Bi
Yunli Bi
XXXianmin Xiao
Xianmin Xiao
Fetal repair of myelomeningocele (MMC) has been proven to be beneficial for the central nervous system development; however, the effect of fetal MMC repair on bladder function remains controversial. The objective of the present study was to establish an early timepoint for in utero MMC repair using a rat model, and to investigate the changes in bladder development subsequent to that intervention. Sprague Dawley rats were divided into the MMC, MMC repair and control groups. MMC rat fetus models were created by treating pregnant rats with all‑trans retinoic acid. The MMC defect was then repaired in utero at embryonic day 17 (E17) using a chitosan‑gelatin membrane patch. Fetal rat bladders were removed at E19 and E21 in each group, as well as at stage E17 in the MMC and control groups. Differential expression of β‑III‑tubulin, α‑smooth muscle actin (α‑SMA), nerve growth factor (NGF) and acetylcholinesterase (AChE) mRNA, and β‑III‑tubulin and α‑SMA protein in the bladder following fetal repair was measured and compared among the three groups. In addition, the expression of NGF mRNA was significantly elevated at E21 in the MMC group compared with that of the control group, however, the level decreased in the repair group at stage E21. The expression of α‑SMA mRNA significantly increased at E19 and then decreased at E21 in the repair group compared with that of the MMC group; however, there were no significant changes in α‑SMA protein following the repair. Furthermore, the repair enhanced β‑III‑tubulin mRNA expression at E19, but ameliorated the decrease of β‑III‑tubulin protein at E21. The expression of AChE mRNA increased in the MMC group at E19 and E21 compared with that of the control group, although it was not significantly altered following repair as compared with that of the MMC group. In conclusion, in the current study, abnormal neuromuscular development was observed in the MMC bladder, which enabled a certain degree of improvement in the in utero MMC repair.

17 March 2022 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JFJin-Wu Fang
Jin-Wu Fang
WFWei-Jia Fu
Wei-Jia Fu
RFRui Feng
Rui Feng
HNHong-Tao Ni
Hong-Tao Ni
CYCao Yun
Cao Yun
XZXiao-Bo Zhang
Xiao-Bo Zhang